Celera Registers Shares with Nasdaq on Eve of Split with ABI

Jun 30, 2008

NEW YORK (GenomeWeb News) – Celera, which is scheduled to officially split tomorrow from parent firm Applera and sister company Applied Biosystems, has registered to have its shares float on the Nasdaq Stock Market.

The firm’s shares currently trade as a tracking stock of Applera on the New York Stock Exchange. Its stock will be delisted from the New York Stock Exchange when the split is finalized.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

An RNAi Approval

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Keep It Going

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Stop It There

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

This Week in PLOS

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Main menu